The established recommended daily dose must not be exceeded
Because the list price cut does not guarantee lower net costs for employers, it is unlikely to materially expand coverage of GLP-1 drugs for obesity, he said
Jean-Pierre Raufman, M.D., Baltimore VA Medical Center (formerly with State University of New York Health Science Center) Selected publications: Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom
Side Effects, Risks, and Safety Considerations The most common side effects are gastrointestinal nausea, vomiting, and diarrhoea with more serious risks including pancreatitis, gallbladder disease, and elevated resting heart rate
doi: 10.1038/s42255-023-00966-w